Navigation Links
National MS Society Reports Sweeping Advances Made in MS Research in 2012
Date:12/27/2012

New York, NY (PRWEB) December 27, 2012

MS research continued to advance on many fronts in 2012. This year saw:

  •     The approval of a second oral therapy for relapsing forms of MS and other emerging treatments progressing through the development pipeline;
  •     The launch of the International Progressive MS Collaborative, the largest effort to date to speed research to stop progressive forms of MS;
  •     The discovery of what could be a target of the immune attack in people with MS may lead to new understanding of the disease and new treatment strategies;
  •     The completion of the first human trial of an experimental therapy targeting myelin repair;
  •     Progress in restoring functions using innovative rehabilitation techniques, including memory enhancement using a technique involving stories and imagery to solidify learning, and improving balance and mobility with specific exercises; and
  •     Advances in uncovering MS triggering factors, bringing us closer to finding ways to prevent the disease; and many other advances pushing us closer to a world free of MS.

The National MS Society continues to propel research forward with a comprehensive strategy aimed at stopping MS, restoring function and ending MS forever (http://www.nationalmssociety.org/research/index.aspx):

  •     This year we invested $44 million in over 350 new and ongoing projects;
  •     Projects include everything from discovery research to the Society’s drug development efforts through Fast Forward® (

Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Page: 1 2 3 4 5 6 7

Related biology technology :

1. The Honey Drop, the Ultimate Fuel for Astronauts, will be Powering Commander Chris Hadfield's Mission to the International Space Station
2. First Warning Systems and Unicorp Biotech International Strategic Partner Letter of Intent Signed Breast Cancer Early Detection
3. Provia Labs Hires Vice President of International Business Development to Expand Global Distribution for its Stem Cell Banking Service and Biobanking Products
4. iLuv Earns International Acclaim for Excellence and Innovation in Product Design
5. How to Answer 20 Tough Medical Sales Job Interview Questions from Nationally Renowned Career Coach, Peggy McKee, CEO of Career Confidential
6. VBI’s Dr. Szczepan Baran is an Invited Speaker at the Swiss Laboratory Animal (SGV) National Meeting
7. 12th U.S. Patent Issued To Dyadic International
8. Dyadic International Reports 2012 Third Quarter Financial Results
9. Boston Childrens Hospital announces international genomics competition winner
10. International Oncology Innovators Meeting in Hamburg
11. Jaipal Reddy, Honble Minister of Science and Technology & Earth Sciences, Inaugurates the International Bioenergy Summit in Delhi
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/24/2014)... , Dec. 23, 2014 Vermillion, ... focused on gynecologic disease, announced today that investors ... , Birchview Fund LLC and several Vermillion directors ... unregistered shares of Vermillion,s common stock and warrants ... in a private placement.  Under ...
(Date:12/24/2014)... NEW YORK , Dec. 23, 2014 /PRNewswire/ ... study of mazindol in children with attention deficit/hyperactivity disorder ... December 2014 . The paper, titled ... attention deficit/hyperactivity disorder" ( Konofal et al, ... eCollection 2014 ) shows that mazindol might be ...
(Date:12/22/2014)... , Dec. 22, 2014  Alternative Energy ... that it has signed a letter of intent ... has developed and patented a nanotechnology-based development platform ... products that enable rapid on-site collection and testing ... and health issues in an immediate, non-invasive and ...
(Date:12/22/2014)... Illinois (PRWEB) December 22, 2014 ITRA ... tenants and occupiers of commercial real estate, has further ... new offices in Perth and Brisbane, Western Australia, reports ... of directors. , ITRA Global / ACORPP (Australian ... totally independent consultancy company providing property services to a ...
Breaking Biology Technology:Vermillion Announces Equity Financing of up to $18.9 Million; Suspends ATM Program 2Vermillion Announces Equity Financing of up to $18.9 Million; Suspends ATM Program 3Vermillion Announces Equity Financing of up to $18.9 Million; Suspends ATM Program 4Vermillion Announces Equity Financing of up to $18.9 Million; Suspends ATM Program 5Redefining ADHD: A New Approach & A Shift of Paradigm in ADHD Therapeutics 2Redefining ADHD: A New Approach & A Shift of Paradigm in ADHD Therapeutics 3ALNE Announces Intention To Acquire BioTechPharma 2ITRA Global Continues International Expansion in Perth and Brisbane, Australia 2
... 3 Inverness Medical Innovations, Inc. (NYSE: IMA ), ... health at home through the merger of rapid diagnostics and health ... Series B Convertible Perpetual Preferred Stock ( IMA-PB). The dividend will ... per share equal to the quotient of (a) $3.00 divided by ...
... , ... that a new market research report is available in ... Perspective , http://www.reportlinker.com/p0164232/Neurostimulation---A-Global-Market-Perspective.html , The ... of aging population, and the resultant rise in age-related ...
... , TUSTIN, Calif., Dec. ... reported completion of patient enrollment in a dose confirmation and ... (GBM), the deadliest form of brain cancer. Cotara is ... as a potential new treatment for GBM. Cotara specifically ...
Cached Biology Technology:Reportlinker Adds Neurostimulation - A Global Market Perspective 2Reportlinker Adds Neurostimulation - A Global Market Perspective 3Reportlinker Adds Neurostimulation - A Global Market Perspective 4Reportlinker Adds Neurostimulation - A Global Market Perspective 5Reportlinker Adds Neurostimulation - A Global Market Perspective 6Peregrine Completes Patient Enrollment in Cotara(R) Dose Confirmation and Dosimetry Brain Cancer Trial 2Peregrine Completes Patient Enrollment in Cotara(R) Dose Confirmation and Dosimetry Brain Cancer Trial 3Peregrine Completes Patient Enrollment in Cotara(R) Dose Confirmation and Dosimetry Brain Cancer Trial 4Peregrine Completes Patient Enrollment in Cotara(R) Dose Confirmation and Dosimetry Brain Cancer Trial 5
(Date:12/10/2014)... Dec. 8, 2014 You,ve been here before: you ... can,t remember your password, site key or the answer to ... first grade teacher? Today, Hoyos Labs ... app that will finally put an end to the frustration ... TM . 1U leverages a user,s smartphone to acquire ...
(Date:12/10/2014)... Dec. 08, 2014 Research and Markets ... of the "Biometrics Market in Japan 2014-2018" ... http://photos.prnewswire.com/prnh/20130307/600769 The integration ... as rural banking and upgradation of the driver,s ... in the market. Besides the aforementioned projects, biometrics ...
(Date:12/4/2014)... , Dec. 3, 2014  Crossmatch™, a ... announced that its DigitalPersona ® Pro Enterprise ... have been deployed throughout First Bank branch locations ... South Carolina and Virginia. First Bank, ... Southern Pines, North Carolina , selected ...
Breaking Biology News(10 mins):The Password is Finally Dead: Launch of 1U Mobile App Eliminates Need for All Usernames and Passwords 2The Password is Finally Dead: Launch of 1U Mobile App Eliminates Need for All Usernames and Passwords 3Biometrics Market in Japan 2014-2018: Key Vendors are DDS, Fujitsu, Hitachi and NEC 2First Bank Partners with Crossmatch to Increase Log In Security 2First Bank Partners with Crossmatch to Increase Log In Security 3
... evidence that most, if not all cases of chronic ... originally proposed by investigators at the Mayo Clinic. ... ongoing pivotal Phase 3 clinical trial for its lead ... amphotericin B 0.01% suspension. In order to be ...
... the Georgia Institute of Technology have developed a new ... of being used in a range of environments including ... the technique, known as thermochemical nanolithography, as a proof ... a variety of nanopatterned structures, including nanocircuits, at a ...
... 10 September 2007 Elsevier, a leading publisher ... announced the availability of more than 4,000 eBooks ... titles published from 1995 to the present. These ... areas, as well as books from renowned imprints ...
Cached Biology News:SinuNase Phase 3 show almost 100 percent of chronic sinusitis cases are from fungal-induced inflamma 2Drawing nanoscale features the fast and easy way 2Drawing nanoscale features the fast and easy way 34,000 e-Books now available on ScienceDirect 2